165 related articles for article (PubMed ID: 35392358)
1. Bioinformatics Method Was Used to Analyze the Highly Expressed Gene FAM83A of Breast Cancer in Young Women.
Tang Y; Wang H; He Q; Chen Y; Wang J
Appl Bionics Biomech; 2022; 2022():5358030. PubMed ID: 35392358
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
[TBL] [Abstract][Full Text] [Related]
3. In silico identification of breast cancer genes by combined multiple high throughput analyses.
Shen D; He J; Chang HR
Int J Mol Med; 2005 Feb; 15(2):205-12. PubMed ID: 15647832
[TBL] [Abstract][Full Text] [Related]
4. FAM83A is a potential biomarker for breast cancer initiation.
Marino N; German R; Podicheti R; Rockey P; Sandusky GE; Temm CJ; Nakshatri H; Addison RJ; Selman B; Althouse SK; Storniolo AMV
Biomark Res; 2022 Feb; 10(1):8. PubMed ID: 35183258
[TBL] [Abstract][Full Text] [Related]
5. Comparison of microarray and sage techniques in gene expression analysis of human glioblastoma.
Kavsan VM; Dmitrenko VV; Shostak KO; Bukreieva TV; Vitak NY; Simirenko OE; Malisheva TA; Shamayev MI; Rozumenko VD; Zozulya YA
Tsitol Genet; 2007; 41(1):36-55. PubMed ID: 17427416
[TBL] [Abstract][Full Text] [Related]
6. FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway.
Rong L; Li H; Li Z; Ouyang J; Ma Y; Song F; Chen Y
Front Med (Lausanne); 2020; 7():608441. PubMed ID: 33344485
[No Abstract] [Full Text] [Related]
7. Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood.
Lauriola M; Ugolini G; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Rivetti S; Mattei G; Coppola D; Strippoli P; Taffurelli M; Solmi R
Int J Oncol; 2010 Aug; 37(2):519-25. PubMed ID: 20596680
[TBL] [Abstract][Full Text] [Related]
8. [High throughput screening and analysis of prostate cancer-related genes through mining databases].
Wu G; Peng L; Jin FS; Li QS
Ai Zheng; 2006 May; 25(5):645-50. PubMed ID: 16687091
[TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
[TBL] [Abstract][Full Text] [Related]
10. B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with β-catenin.
Zhou C; Zhu X; Liu N; Dong X; Zhang X; Huang H; Tang Y; Liu S; Hu M; Wang M; Deng X; Li S; Zhang R; Huang Y; Lyu H; Xiao S; Luo S; Ali DW; Michalak M; Chen XZ; Wang Z; Tang J
Signal Transduct Target Ther; 2023 Feb; 8(1):66. PubMed ID: 36797256
[TBL] [Abstract][Full Text] [Related]
11. Family with sequence similarity 83 member A promotes tumor cell proliferation and metastasis and predicts poor prognosis in cervical cancer.
Liu T; Chen J; Du Q; Liu J; Chen M; Ooi S; Huang J; Wang W; Yao S
Pathol Res Pract; 2021 Jun; 222():153450. PubMed ID: 33962175
[TBL] [Abstract][Full Text] [Related]
12. miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A.
Liu C; Jiang Y; Han B
Cancer Manag Res; 2020; 12():12623-12633. PubMed ID: 33324107
[TBL] [Abstract][Full Text] [Related]
13. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
Hu H; Wang F; Wang M; Liu Y; Wu H; Chen X; Lin Q
Int J Med Sci; 2020; 17(6):807-814. PubMed ID: 32218702
[TBL] [Abstract][Full Text] [Related]
14. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice.
Lee SY; Meier R; Furuta S; Lenburg ME; Kenny PA; Xu R; Bissell MJ
J Clin Invest; 2012 Sep; 122(9):3211-20. PubMed ID: 22886303
[TBL] [Abstract][Full Text] [Related]
15. High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma.
Fei W; Yan Y; Liu G; Peng B; Liu Y; Chen Q
PeerJ; 2023; 11():e16306. PubMed ID: 37904848
[TBL] [Abstract][Full Text] [Related]
16. FAM83A exerts tumor‑suppressive roles in cervical cancer by regulating integrins.
Xu J; Lu W
Int J Oncol; 2020 Aug; 57(2):509-521. PubMed ID: 32626940
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
[No Abstract] [Full Text] [Related]
18. Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma.
Liu X; Fu M; Xia D; Ji Z; Hu N; Leng Z; Xie W; Fang Y; Zhang J
J Oncol; 2022; 2022():8767333. PubMed ID: 36245969
[TBL] [Abstract][Full Text] [Related]
19. FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma.
Wang G; Li X; Yao Y; Jiang Z; Zhou H; Xie K; Luo J; Shen Y
Oncol Lett; 2021 Apr; 21(4):297. PubMed ID: 33732373
[TBL] [Abstract][Full Text] [Related]
20. FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC.
Zhou F; Geng J; Xu S; Meng Q; Chen K; Liu F; Yang F; Pan B; Yu Y
Aging (Albany NY); 2019 Aug; 11(16):6069-6088. PubMed ID: 31444970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]